Stable CMV-specific CD4+ T-cell responses have been associated with control of late CMV reactivation in transplant recpient [4], [8], [22]; whereas CMV-specific CD8+ T-cells seem to be more important in primary infection and during early phases after transplantation [3], [6]. The gene discussed is CD4; the disease is infection.